Josep Rodes-cabau
Clinical trials sponsored by Josep Rodes-cabau, explained in plain language.
-
HALTI trial: a step toward fewer pills after PFO closure?
Disease control Recruiting nowThis study looks at whether young people (60 or younger) who had a stroke and then a procedure to close a hole in their heart (called PFO closure) can safely stop taking blood thinners one year later. The goal is to see if stopping these medications increases the risk of another …
Phase: NA • Sponsor: Josep Rodes-Cabau • Aim: Disease control
Last updated May 26, 2026 04:40 UTC
-
Heart hole closure may shield seniors from second stroke
Disease control Recruiting nowThis study looks at whether closing a common heart defect called PFO (a small hole between the heart's upper chambers) can help prevent another stroke in people over 60 who have had a stroke with no clear cause. About 714 older adults will either get medication alone or medicatio…
Phase: NA • Sponsor: Josep Rodes-Cabau • Aim: Disease control
Last updated May 26, 2026 04:31 UTC
-
Is frailty the hidden risk in heart-closure procedures?
Knowledge-focused Recruiting nowThis study is observing 500 adults who are having a procedure called left atrial appendage closure (LAAC) to prevent strokes. Researchers want to see how frailty—a measure of weakness and vulnerability—affects their recovery, complications, and quality of life. No new treatment i…
Sponsor: Josep Rodes-Cabau • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC